Company 4 Sc AG Xetra
Equities
VSC1k
DE0005753818
Biotechnology & Medical Research
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Development of Small-Molecule Drugs
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -30.28% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other Countries
88.8
%
| 0 | 68.8 % | 0 | 88.8 % | -10.00% |
Germany
11.2
%
| 0 | 31.2 % | 0 | 11.2 % | -75.00% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,114,009 | 2,698,840 ( 26.68 %) | 0 | 26.68 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+17.04% | 124B | |
+18.84% | 112B | |
+3.52% | 22.94B | |
-11.50% | 17.02B | |
-16.50% | 16.88B | |
-39.57% | 16.87B | |
+3.56% | 13.63B | |
+24.15% | 11.61B | |
+106.49% | 10.31B |